nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—Methylation—CYP1A2—chronic obstructive pulmonary disease	0.0185	0.0956	CbGpPWpGaD
Entacapone—UGT1A9—Arylamine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0167	0.0862	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0116	0.0598	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00887	0.0458	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00841	0.0434	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00694	0.0358	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00532	0.0274	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00504	0.026	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00452	0.0233	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00391	0.0202	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00387	0.02	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00327	0.0169	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00325	0.0168	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00308	0.0159	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00271	0.014	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00271	0.014	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00251	0.013	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.00249	0.0129	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00238	0.0123	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00237	0.0122	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00236	0.0122	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00234	0.0121	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00232	0.012	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00229	0.0118	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00226	0.0117	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00195	0.0101	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00192	0.00992	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.0019	0.00982	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00188	0.00969	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00177	0.00913	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00173	0.00894	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00169	0.00872	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00163	0.00839	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00159	0.00819	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00157	0.00808	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00155	0.00798	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.00149	0.00771	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00147	0.00756	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00146	0.00753	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00144	0.00742	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00144	0.00742	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00138	0.00714	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00137	0.00708	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00136	0.00704	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00136	0.007	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.00132	0.00679	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00119	0.00616	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00118	0.00611	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00116	0.00598	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00114	0.00588	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00112	0.0058	CbGpPWpGaD
Entacapone—COMT—Metabolism—APIP—chronic obstructive pulmonary disease	0.00111	0.00574	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00108	0.00559	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00107	0.00552	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.00102	0.00528	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.001	0.00518	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000996	0.00514	CbGpPWpGaD
Entacapone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00098	0.00122	CcSEcCtD
Entacapone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000978	0.00121	CcSEcCtD
Entacapone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000977	0.00121	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000975	0.00121	CcSEcCtD
Entacapone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000973	0.00121	CcSEcCtD
Entacapone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00097	0.0012	CcSEcCtD
Entacapone—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000968	0.0012	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000964	0.00498	CbGpPWpGaD
Entacapone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00096	0.00119	CcSEcCtD
Entacapone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00096	0.00119	CcSEcCtD
Entacapone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000959	0.00119	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000955	0.00493	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000951	0.00491	CbGpPWpGaD
Entacapone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00117	CcSEcCtD
Entacapone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000946	0.00117	CcSEcCtD
Entacapone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000945	0.00117	CcSEcCtD
Entacapone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000943	0.00117	CcSEcCtD
Entacapone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000942	0.00117	CcSEcCtD
Entacapone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000942	0.00117	CcSEcCtD
Entacapone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000941	0.00117	CcSEcCtD
Entacapone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000941	0.00117	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000938	0.00484	CbGpPWpGaD
Entacapone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.00116	CcSEcCtD
Entacapone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000933	0.00116	CcSEcCtD
Entacapone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000933	0.00116	CcSEcCtD
Entacapone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000933	0.00116	CcSEcCtD
Entacapone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00093	0.00115	CcSEcCtD
Entacapone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000925	0.00115	CcSEcCtD
Entacapone—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000924	0.00115	CcSEcCtD
Entacapone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00114	CcSEcCtD
Entacapone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000921	0.00114	CcSEcCtD
Entacapone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000914	0.00113	CcSEcCtD
Entacapone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00091	0.00113	CcSEcCtD
Entacapone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000907	0.00112	CcSEcCtD
Entacapone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000897	0.00111	CcSEcCtD
Entacapone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000897	0.00111	CcSEcCtD
Entacapone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000893	0.00111	CcSEcCtD
Entacapone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00111	CcSEcCtD
Entacapone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000891	0.00111	CcSEcCtD
Entacapone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000889	0.0011	CcSEcCtD
Entacapone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000881	0.00109	CcSEcCtD
Entacapone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000877	0.00109	CcSEcCtD
Entacapone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000877	0.00109	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000875	0.00109	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000875	0.00109	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000874	0.00451	CbGpPWpGaD
Entacapone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000869	0.00108	CcSEcCtD
Entacapone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000869	0.00108	CcSEcCtD
Entacapone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00107	CcSEcCtD
Entacapone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000863	0.00107	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000862	0.00445	CbGpPWpGaD
Entacapone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00086	0.00107	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000857	0.00106	CcSEcCtD
Entacapone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000856	0.00106	CcSEcCtD
Entacapone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.00106	CcSEcCtD
Entacapone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000854	0.00106	CcSEcCtD
Entacapone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000854	0.00106	CcSEcCtD
Entacapone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000851	0.00106	CcSEcCtD
Entacapone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000847	0.00105	CcSEcCtD
Entacapone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00105	CcSEcCtD
Entacapone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00105	CcSEcCtD
Entacapone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000845	0.00105	CcSEcCtD
Entacapone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.00104	CcSEcCtD
Entacapone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000837	0.00104	CcSEcCtD
Entacapone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000836	0.00104	CcSEcCtD
Entacapone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000834	0.00103	CcSEcCtD
Entacapone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000832	0.00103	CcSEcCtD
Entacapone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00103	CcSEcCtD
Entacapone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00103	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000828	0.00428	CbGpPWpGaD
Entacapone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00103	CcSEcCtD
Entacapone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000828	0.00103	CcSEcCtD
Entacapone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.00103	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000826	0.00102	CcSEcCtD
Entacapone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00102	CcSEcCtD
Entacapone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00102	CcSEcCtD
Entacapone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00102	CcSEcCtD
Entacapone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00102	CcSEcCtD
Entacapone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00082	0.00102	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000817	0.00422	CbGpPWpGaD
Entacapone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.00101	CcSEcCtD
Entacapone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000812	0.00101	CcSEcCtD
Entacapone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000811	0.00101	CcSEcCtD
Entacapone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000808	0.001	CcSEcCtD
Entacapone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000806	0.001	CcSEcCtD
Entacapone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000804	0.000998	CcSEcCtD
Entacapone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000804	0.000997	CcSEcCtD
Entacapone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000802	0.000995	CcSEcCtD
Entacapone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000799	0.000991	CcSEcCtD
Entacapone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000799	0.000991	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000799	0.00412	CbGpPWpGaD
Entacapone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00099	CcSEcCtD
Entacapone—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000798	0.00099	CcSEcCtD
Entacapone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.000987	CcSEcCtD
Entacapone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000795	0.000986	CcSEcCtD
Entacapone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000793	0.000983	CcSEcCtD
Entacapone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000791	0.000982	CcSEcCtD
Entacapone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000791	0.000982	CcSEcCtD
Entacapone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000791	0.00098	CcSEcCtD
Entacapone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.000978	CcSEcCtD
Entacapone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.000976	CcSEcCtD
Entacapone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000785	0.000974	CcSEcCtD
Entacapone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000785	0.000974	CcSEcCtD
Entacapone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.000971	CcSEcCtD
Entacapone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.00097	CcSEcCtD
Entacapone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.000962	CcSEcCtD
Entacapone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.000962	CcSEcCtD
Entacapone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000769	0.000954	CcSEcCtD
Entacapone—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000769	0.000954	CcSEcCtD
Entacapone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000763	0.000946	CcSEcCtD
Entacapone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000763	0.000946	CcSEcCtD
Entacapone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000759	0.000942	CcSEcCtD
Entacapone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000759	0.000942	CcSEcCtD
Entacapone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000759	0.000942	CcSEcCtD
Entacapone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000759	0.000942	CcSEcCtD
Entacapone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000757	0.000938	CcSEcCtD
Entacapone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000751	0.000931	CcSEcCtD
Entacapone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00075	0.000931	CcSEcCtD
Entacapone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00075	0.00093	CcSEcCtD
Entacapone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00075	0.00093	CcSEcCtD
Entacapone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000747	0.000927	CcSEcCtD
Entacapone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000747	0.000927	CcSEcCtD
Entacapone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.000925	CcSEcCtD
Entacapone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.000924	CcSEcCtD
Entacapone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000744	0.000922	CcSEcCtD
Entacapone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000744	0.000922	CcSEcCtD
Entacapone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000742	0.00092	CcSEcCtD
Entacapone—COMT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000737	0.0038	CbGpPWpGaD
Entacapone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000736	0.000913	CcSEcCtD
Entacapone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000732	0.000908	CcSEcCtD
Entacapone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00072	0.000893	CcSEcCtD
Entacapone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.000889	CcSEcCtD
Entacapone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.000889	CcSEcCtD
Entacapone—COMT—Metabolism—GC—chronic obstructive pulmonary disease	0.000717	0.0037	CbGpPWpGaD
Entacapone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.000878	CcSEcCtD
Entacapone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000708	0.000878	CcSEcCtD
Entacapone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000707	0.000877	CcSEcCtD
Entacapone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000705	0.000875	CcSEcCtD
Entacapone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000693	0.00086	CcSEcCtD
Entacapone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.000855	CcSEcCtD
Entacapone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000689	0.000855	CcSEcCtD
Entacapone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000679	0.000843	CcSEcCtD
Entacapone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000679	0.000843	CcSEcCtD
Entacapone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000678	0.000841	CcSEcCtD
Entacapone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000675	0.000837	CcSEcCtD
Entacapone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.000829	CcSEcCtD
Entacapone—UGT1A9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000666	0.00344	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000666	0.00344	CbGpPWpGaD
Entacapone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000666	0.000825	CcSEcCtD
Entacapone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000657	0.000815	CcSEcCtD
Entacapone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.000815	CcSEcCtD
Entacapone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.000807	CcSEcCtD
Entacapone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000647	0.000803	CcSEcCtD
Entacapone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000644	0.000798	CcSEcCtD
Entacapone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.000796	CcSEcCtD
Entacapone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000635	0.000788	CcSEcCtD
Entacapone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.000788	CcSEcCtD
Entacapone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000622	0.000772	CcSEcCtD
Entacapone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00077	CcSEcCtD
Entacapone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000759	CcSEcCtD
Entacapone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000611	0.000757	CcSEcCtD
Entacapone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.000757	CcSEcCtD
Entacapone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000606	0.000751	CcSEcCtD
Entacapone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000606	0.000751	CcSEcCtD
Entacapone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000605	0.00075	CcSEcCtD
Entacapone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000605	0.00075	CcSEcCtD
Entacapone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000605	0.00075	CcSEcCtD
Entacapone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000602	0.000746	CcSEcCtD
Entacapone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000602	0.000746	CcSEcCtD
Entacapone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000601	0.000746	CcSEcCtD
Entacapone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000601	0.000745	CcSEcCtD
Entacapone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0006	0.000744	CcSEcCtD
Entacapone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.0006	0.000744	CcSEcCtD
Entacapone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000598	0.000742	CcSEcCtD
Entacapone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000593	0.000736	CcSEcCtD
Entacapone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000593	0.000735	CcSEcCtD
Entacapone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000591	0.000733	CcSEcCtD
Entacapone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000591	0.000733	CcSEcCtD
Entacapone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000589	0.000731	CcSEcCtD
Entacapone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000584	0.000725	CcSEcCtD
Entacapone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000582	0.000722	CcSEcCtD
Entacapone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000581	0.00072	CcSEcCtD
Entacapone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000581	0.00072	CcSEcCtD
Entacapone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.000715	CcSEcCtD
Entacapone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000575	0.000713	CcSEcCtD
Entacapone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000573	0.00071	CcSEcCtD
Entacapone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.000709	CcSEcCtD
Entacapone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000572	0.000709	CcSEcCtD
Entacapone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000571	0.000708	CcSEcCtD
Entacapone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.000708	CcSEcCtD
Entacapone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00057	0.000708	CcSEcCtD
Entacapone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.000705	CcSEcCtD
Entacapone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00056	0.000695	CcSEcCtD
Entacapone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000559	0.000693	CcSEcCtD
Entacapone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000552	0.000685	CcSEcCtD
Entacapone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00055	0.000682	CcSEcCtD
Entacapone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000672	CcSEcCtD
Entacapone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.000668	CcSEcCtD
Entacapone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000536	0.000665	CcSEcCtD
Entacapone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000663	CcSEcCtD
Entacapone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00066	CcSEcCtD
Entacapone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000656	CcSEcCtD
Entacapone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00052	0.000645	CcSEcCtD
Entacapone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000512	0.000635	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000503	0.000624	CcSEcCtD
Entacapone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000497	0.000617	CcSEcCtD
Entacapone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000494	0.000612	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000475	0.00245	CbGpPWpGaD
Entacapone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00047	0.000583	CcSEcCtD
Entacapone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00047	0.000583	CcSEcCtD
Entacapone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.000579	CcSEcCtD
Entacapone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000466	0.000578	CcSEcCtD
Entacapone—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000463	0.000574	CcSEcCtD
Entacapone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000445	0.000552	CcSEcCtD
Entacapone—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000441	0.00228	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000438	0.00226	CbGpPWpGaD
Entacapone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000436	0.000541	CcSEcCtD
Entacapone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00043	0.000533	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	0.000429	0.00222	CbGpPWpGaD
Entacapone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.000532	CcSEcCtD
Entacapone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000528	CcSEcCtD
Entacapone—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000423	0.000525	CcSEcCtD
Entacapone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000418	0.000518	CcSEcCtD
Entacapone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000516	CcSEcCtD
Entacapone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000415	0.000515	CcSEcCtD
Entacapone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000413	0.000512	CcSEcCtD
Entacapone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000407	0.000505	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000406	0.0021	CbGpPWpGaD
Entacapone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000498	CcSEcCtD
Entacapone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000496	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000399	0.00206	CbGpPWpGaD
Entacapone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000394	0.000489	CcSEcCtD
Entacapone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000393	0.000487	CcSEcCtD
Entacapone—COMT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000392	0.00202	CbGpPWpGaD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000486	CcSEcCtD
Entacapone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00039	0.000483	CcSEcCtD
Entacapone—COMT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000387	0.002	CbGpPWpGaD
Entacapone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.000475	CcSEcCtD
Entacapone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000469	CcSEcCtD
Entacapone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000372	0.000461	CcSEcCtD
Entacapone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00046	CcSEcCtD
Entacapone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000455	CcSEcCtD
Entacapone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000365	0.000453	CcSEcCtD
Entacapone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000447	CcSEcCtD
Entacapone—COMT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000353	0.00182	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000344	0.000427	CcSEcCtD
Entacapone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000427	CcSEcCtD
Entacapone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000424	CcSEcCtD
Entacapone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000421	CcSEcCtD
Entacapone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000413	CcSEcCtD
Entacapone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000407	CcSEcCtD
Entacapone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000407	CcSEcCtD
Entacapone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000406	CcSEcCtD
Entacapone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000404	CcSEcCtD
Entacapone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000404	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.00168	CbGpPWpGaD
Entacapone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000401	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000318	0.00164	CbGpPWpGaD
Entacapone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000386	CcSEcCtD
Entacapone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000383	CcSEcCtD
Entacapone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.000383	CcSEcCtD
Entacapone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000372	CcSEcCtD
Entacapone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000371	CcSEcCtD
Entacapone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000371	CcSEcCtD
Entacapone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000345	CcSEcCtD
Entacapone—COMT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000271	0.0014	CbGpPWpGaD
Entacapone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000336	CcSEcCtD
Entacapone—COMT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000268	0.00138	CbGpPWpGaD
Entacapone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000332	CcSEcCtD
Entacapone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000321	CcSEcCtD
Entacapone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00031	CcSEcCtD
Entacapone—COMT—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000249	0.00129	CbGpPWpGaD
Entacapone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000298	CcSEcCtD
Entacapone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000296	CcSEcCtD
Entacapone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000295	CcSEcCtD
Entacapone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000294	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00122	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000235	0.00121	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000232	0.0012	CbGpPWpGaD
Entacapone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000278	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000216	0.00112	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000212	0.00109	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.00101	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000163	0.000839	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—chronic obstructive pulmonary disease	0.000161	0.00083	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00016	0.000828	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000154	0.000794	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000149	0.000771	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.000731	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	9.63e-05	0.000497	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	9.21e-05	0.000475	CbGpPWpGaD
